MallickN.P., JonesE., SelwoodN.The European (European Dialysis and Transplant Association-European Renal Association) registry.Am J Kidney Dis1995; 25: 176–87.
5.
AgodoaL.Y., EggersP.W.Renal replacement therapy in the United States-data from the United States Renal Data System.Am J Kidney Dis1995; 25: 119–33.
6.
NissensonA.R., PrichardS.S., ChengI.P.K.Nonmedical factors that impact on ESRD modality selection.Kidney Int1993; 43(Suppl 40): S120–7.
7.
MaiorcaR., CancariniG.C.Outcome of peritoneal dialysis-comparative studies. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 699–734.
8.
HolleyJ.L., BernardiniJ., PirainoB.Infecting organisms in CAPD-patients on the y set.Am J Kidney Dis1994; 23: 569–73.
9.
Canada-USA (CANUSA) Peritoneal Dialysis Study Group.Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
10.
MaiorcaR., BrunoriG., ZubaniR.Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study.Nephrol Dial Transplant1995; 10: 2295–305.
11.
HartyJ., VenningM., GokalR.Dialysis adequacy and nutritional status in CAPD. Is there a link?Semin Dial1995; 8: 62–7.
12.
MaiorcaR., CancariniG.C., ZubaniR.CAPD viability: a long-term comparison with hemodialysis.Perit Dial Int1996; 16: 276–87.
13.
BernardiniJ., PirainoB., HolleyJ., JohnstoneJ.R., LutesR.A randomised trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment applied to the exit site versus cyclical oral rifampicin.Am J Kidney Dis1996; 27: 695–700.
